General Electric: The Crazy Ex-Girlfriend I'm Now About To Marry

MannKind (MNKD) investors let out a bit of a Bronx cheer this week as Afrezza scripts surpassed the 500 mark for the first time since MannKind assumed full responsibility for marketing the inhaled insulin, and...

Continue reading at Seeking Alpha →
Recommended posts powered by Google